Dupilumab and quality of life in adults with atopic dermatitis

被引：0
|
作者：
不详
机构：
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2018年 / 138卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：479 / 479
页数：1
相关论文
共 50 条
  • [21] Quality of life in atopic dermatitis
    Salloum, SR
    Parsons, S
    Hiliman, KS
    Harkonen, WS
    Dicanzio, J
    Schneider, LC
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S46 - S46
  • [22] Dupilumab for treatment of atopic dermatitis
    Seegraeber, Marlene
    Srour, Jerome
    Walter, Alexandra
    Knop, Macarena
    Wollenberg, Andreas
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (05) : 467 - 474
  • [23] Dupilumab for the treatment of atopic dermatitis
    不详
    PEDIATRIC DERMATOLOGY, 2021, 38 (06) : E643 - E644
  • [24] Dupilumab for the Treatment of Atopic Dermatitis
    Ferreira, S.
    Torres, T.
    ACTAS DERMO-SIFILIOGRAFICAS, 2018, 109 (03): : 230 - 240
  • [25] Atopic dermatitis treatment with dupilumab in real life - the experience of a center
    Rodrigues, M. A.
    Selores, M.
    Torres, T.
    ALLERGY, 2020, 75 : 459 - 459
  • [26] The use of dupilumab in atopic dermatitis
    Heratizadeh, A.
    Werfel, T.
    ALLERGOLOGIE, 2019, 42 (06) : 258 - 265
  • [27] Effectiveness of dupilumab in atopic dermatitis
    Romero Puerto, J.
    Garcia Marin, J.
    Fages Perez, M.
    Martinez-Echevarria Gil-Delgado, Z.
    Moreno Herrera, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1555 - 1555
  • [28] Severe atopic dermatitis and dupilumab
    Bernardo, Wanderley
    Bernardo, Luca Silveira
    Baroni, Juliana Hegedus
    Simoes, Ricardo dos Santos
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (01): : 2 - 6
  • [29] The use of dupilumab in atopic dermatitis
    Heratizadeh, A.
    Werfel, T.
    DERMATOLOGIE IN BERUF UND UMWELT, 2020, 68 (01) : 27 - 34
  • [30] Dupilumab nonresponders in atopic dermatitis
    Leung, Donald Y. M.
    Ong, Peck Y.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 (03) : 267 - 268
12345